Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: too early to take shortcuts?
Open Access
- 31 March 2004
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 40 (3) , 536-538
- https://doi.org/10.1016/j.jhep.2004.01.012
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirinJournal of Hepatology, 2004
- Management of hepatitis CJournal of Hepatology, 2003
- Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen AssayJournal of Clinical Microbiology, 2003
- Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzerTransfusion, 2003
- Total HCV core antigen assay: A new marker of hepatitis C viremia for monitoring the progress of therapyJournal of Medical Virology, 2003
- Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replicationHepatology, 2002
- Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core AntigenJournal of Clinical Microbiology, 2001
- Hepatitis C virus core protein: intriguing properties and functional relevanceFEMS Microbiology Letters, 2001
- Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNAHepatology, 2000
- Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremiaJournal of Hepatology, 1995